FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use
FDA refuses entry of collagen implants for aesthetic use.
What changed & why it matters
Med Spa Radar recorded an FDA import refusal at the federal level, dated July 31, 2026, in the Aesthetic Injectables category.
An import refusal marks a shipment the FDA stopped at the U.S. border as violative — the gray-market corridor a med spa must never source injectables from. Foreign, unapproved, or misbranded product refused at import is exactly what surfaces when a practice buys outside verified US-licensed 503A/503B or FDA-registered channels.
- Type
- FDA Import Refusal
- Jurisdiction
- Federal
- Category
- Aesthetic Injectables
- Recorded
- July 31, 2026
What this means for your specific practice — the exact step to take, the deadline to calendar, or the supplier detail to check — is in the member "what to do" below. This page is the free record of what changed and why it matters.
Firm inspection: Voluntary Action Indicated
This firm’s most recent FDA inspection was classified Voluntary Action Indicated (VAI) — objectionable conditions FDA expects the firm to correct.
Source: FDA Data Dashboard inspection classifications (most recent, by firm FEI).
What to do
Free weekly Brief
Get the changes that matter in plain English, every week — and be alerted when the rules move. No charge.
Members get the full “what to do” on every alert — in real time, for your states. Become a member →
The FDA record
- Firm
- Revance Therapeutics, Inc
- Origin
- Newark, United States
- Product
- Implant, Dermal, Collagen For Aesthetic Use
- FDA classification
- General and Plastic Surgery Medical Devices
- Refused
- Jul 31, 2026
- FDA district
- Division of Southeast Imports
- Firm FEI
- 3007772056
- FDA shipment ID
- 1FX-6724044-9/10001/1
Why FDA refused it
Misbranding502(a),(f)(1), 801(a)(3); MISBRANDING
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a prescription device that appears to not feature a prescription device legend as required by 21 CFR 801.109.
FDA charge codes on this record: 84 (Misbranding) · 9999973 (no public definition) · 9999974 (no public definition) · 9999976 (no public definition). Definitions via the FDA Refusal Charges Reference.
Verify at FDA
FDA doesn’t publish a page per refusal. Open the FDA Import Refusals database and search by shipment ID 1FX-6724044-9/10001/1 (or firm FEI 3007772056), refused Jul 31, 2026.
FDA Import Refusal · FDA Import Refusals database ↗FDA record · Revance Therapeutics, Inc · Newark · plastic-surgery device · refused as misbranding
Related alerts
- FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
- FDA import refusal: Lidocaine (Belgium)
- FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Brazil)
- FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
- FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
- FDA import refusal: Acid, Hyaluronic, Intraarticular (Sweden)
Monitoring, not legal advice.